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Abstract. Adducin is a membrane-skeletal protein
which is a candidate to promote assembly of a spec-
trin-actin network in erythrocytes and at sites of cell-
cell contact in epithelial tissues. The complete se-
quence of both subunits of human adducin, alpha (737
amino acids), and beta (726 amino acids) has been
deduced by analysis of the cDNAs . The two subunits
have strikingly conserved amino acid sequences with
49% identity and 66% similarity, suggesting evolution
by gene duplication. Each adducin subunit has three
distinct domains: a 39-kD NH2-terminal globular pro-
tease-resistant domain, connected by a 9-kD domain
to a 33-kD COOH-terminal protease-sensitive tail
comprised almost entirely of hydrophilic amino acids.
The tail is responsible for the high frictional ratio of
adducin noted previously, and was visualized by EM .
The head domains of both adducin subunits exhibit a
limited sequence similarity with the NH2-terminal ac-
LASMA membranes of eukaryotic cells contain a sys-
tem of structural proteins known as the spectrin-based
membrane skeleton that has a general role in organi
zation ofcertain integral membrane proteins and of coupling
these proteins to cytoplasmic proteins (2, 16, 29) . Spectrin,
the principal component of the membrane skeleton, is a rod-
shaped protein that associates with F-actin ateach end. Spec-
trin and actin together with accessory proteins form a regu-
lar geodesic domelike structure in erythrocytes where short
actin filaments are associated with five and seven spectrin
molecules to form a polygonal network (5, 28). The striking
images of the spectrin skeleton raise the issue of how such
a structure could be assembled and has focused attention on
the accessory proteins that interact with spectrin and actin
at spectrin-actin junctions (1) .
Adducin is a membrane-skeletal protein that promotes as-
sociation of spectrin with actin, and this interaction is regu-
lated by calcium/calmodulin (14, 31) . Adducin is comprised
of two subunits with M 103,000 (alpha) and 97,000 (beta)
and was originally purified from human erythrocytes based
on its calmodulin-binding activity (13) . Adducin also is a
substrate for protein kinase C in intact cellsas well as under
in vitro conditions (6, 27, 33, 39). A protein closely related
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tin-binding motif present in members of the spectrin
superfamily and actin gelation proteins. The 000H-
termini of both subunits contain an identical, highly
basic stretch of 22 amino acids with sequence similar
ity to the MARCKS protein. Predicted sites of phos-
phorylation by protein kinase C include the 000H-
terminus and sites at the junction of the head and tail .
Northern blot analysis of mRNA from rat tissues, K562
erythroleukemia cells and reticulocytes has shown that
alpha adducin is expressed in all the tissues tested as a
single message size of 4 kb. In contrast, beta adducin
shows tissue specific variability in size of mRNA and
level of expression. A striking divergence between al-
pha and beta mRNAs was noted in reticulocytes, where
alpha adducin mRNA is present in at least 20-fold
higher levels than that of beta adducin. The beta sub-
unit thus is a candidate to perform a limiting role in
assembly of functional adducin molecules.
to erythrocyte adducin has been purified from brain mem-
branes (3) and immunologically related isoforms are present
in other tissues and cell types including liver, kidney, lung
and testes, and various cultured cells (3, 24, 40). Adducin
is localized at sites of cell-cell contact in epithelial tissues
and in cultured cells such as keratinocytes and MDCK cells
(24). Co-localization of adducin with spectrin in a detergent-
stable complex at sites of cell-cell contact and the ability to
promote formation of spectrin-actin complexes have sug-
gested that adducin has a role in assembly ofa spectrin-actin
network (14, 24).
Limited proteolytic digestion of adducin has revealed that
each subunit is comprised oftwo distinct domains (23). The
NH2-terminal 39-kD region is protease-resistant and glob-
ular in shape while the C0011-terminal domains are ex-
tremely protease sensitive. These properties suggested that
adducin is shaped like a ball with a tail on one end, although
the tail was not noted previously by rotary shadowing EM
(13). The COOH-terminal domains contain phosphorylation
sites, the binding site for calmodulin, and are required for
association with spectrin and actin (23) .
In this study, we have determined the amino acid sequence
for both subunits of adducin from analysis of their cDNAs.
665The subunits are remarkably similar throughout their se-
quences, with 49% identity and 66% similarity. Both
subunits contain a hydrophilic C0011-terminal region corre-
sponding to the protease-sensitive domain noted previously.
A single alpha adducin mRNA is expressed in all tissues
while beta adducin mRNA has tissue-specific variability.
Materials and Methods
Protein Isolation and Sequencing
Adducin and its NHZ-terminal protease resistant domains were purified
from human erythrocytes essentially as described (23). Small peptides,
which were present in tryptic digests of adducin, were separated from the
protease-resistant domain by passage through a Mono Q column equili-
brated with 10 mM sodium phosphate, pH 7.5, 1 mM NaEDTA, 1 mM
NaN3, 0.05% Tween 20, 0.5 mM DTT, pH 7.5 and loaded on a Poly F re-
verse phasecolumn. The column was eluted using a linear gradient of0.2%
TEA in water to0.1% TEAin acetonitrile. Fractions containing a single band
on SDS-polyacrylamide gels were sequenced directly. Impure fractions
were pooled in small batches, diluted with 0.2 % (vol/vol) TEA, loaded on
a Vydac C18 column and eluted as described above. Fractions containing
a singleband were sequenced. Some fractions were sequenced after transfer
to Immobilon paper (Millipore Corp., Bedford, MA) as described (9, 30).
Smaller bands obtained after chymotryptic digestion of the protease resis-
tant domains were also sequenced after transfer to Immobilon. Peptides
were sequenced on an Applied Biosystems Protein Sequencer by Judy
Phelps in the Howard Hughes Biopolymer facility (Duke University Medi-
cal Center).
Cloning and Sequencing ofAdducin cDNAs
Unless specified, molecular cloning methods were performed essentially as
described by Sambrook et al. (1989). cDNA clones for adducin were ini-
tially isolated by screening a lambda gt 11 human reticulocyte library (7)
withan affinity-purified antibody against adducin. Clone R8, whichencodes
alpha adducin (see Results), was obtained on antibody screening, subcloned
into pBluescriptSK II (+) (Stratagene, La Jolla, CA) and sequenced in both
directions using the dideoxy chaintermination method (36). Subsequental-
pha adducin clones were isolated from either the human reticulocyte or a
K562 (human erythroleukemic cell line) 5' stretch lambda gt 11 library
(Clontech, Palo Alto, CA) using 32P-labeled cDNA fragments prepared by
randonily primed DNA synthesis (Multiprime System; Àmersham Corp.,
Arlington Heights, IL) . Clones forbeta adducin were isolated by screening
the K562 library with a 300-bp cDNA probe. The probe was synthesized
by reverse transcriptase-polymerasechain reactionofK562 cell RNA using
primers derived from a partial mouse spleen cDNA sequence (35). The in-
serts were subcloned into pBluescript KS II (+) (Stratagene) and sequenced
in both directions using the dideoxy chain-termination method.
Expression ofPartial AlphaAdducin in
Escherichia coli
Clone R8 was ligated in a unique EcoRl site in pGEMEX-1 (Promega Bio-
tec, Madison, WI) which contains a T7 RNA polymerase promoter. The
recombinant plasmid was usedtotransform JM109 (DE3), a non-expressor
strainof E. coli, and plasmids were identified containing the correct orien-
tation of the clone in the plasmid. An expressor strain of E. coli (BL 21)
was subsequently transformed with the selected recombinant plasmid (38).
Bacteria were induced with IPTG to express a fusion protein which con-
tained 30 kD of NHZ-terminal viral protein Gene 10 sequence followed by
the polypeptide encoded by clone R8.
Antibodies
Antibodies to individual subunits of adducin were raised by immunizing
rabbits with bands cut from SDS-polyacrylamide gels and affinity purified
using either intact adducin or the expressed fusion protein coupled to
CNBr-activated sepharose as an immunoadsorbant (8) .
Northern and Southern BlotAnalyses
Total RNA from rat tissues and K562 cells (3 x 108 cultured cells) was ex-
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tracted using RNAzol (Cinna/Biotex) according to instructions providedby
the manufacturer. Human reticulocyte RNA was prepared from blood ob-
tained from patients with polycythemia or undergoing exchange transfitsions
(17) with the modification that the acid precipitate was extracted with four
volumes of RNAzol and RNA purified as for rat tissues. Poly A' RNA was
isolated from total RNA by adsorption to oligo dTcellulose. Chromosomal
localization of alpha and beta adducin was evaluated using blots of DNA
from human/hamster cell hybrids (Bios Corp., New Haven, CT) .
Electron Microscopy
200 Al of 53 pg/ml adducin and 57 pg/ml NHZ-terminal domains in 10 MM
sodium phosphate, pH 7.5, 1 mM EDTA, 1 mM NaN3, 0.5 mM DTT, were
loaded on a 6.0-ml gradient of 15-40% glycerol in 0.1 M ammonium bicar-
bonate, 5 mM DTT. The gradients were centrifuged at 50,000 rpm for 15 h
in SW-50.1. Fractions were collected (25014) and run on a SDS-polyacryl-
amide gel. Fractions containing protein were used for low angle rotary
shadowing with platinum andcarbon (12). Negative stainingwas performed
by applying 2-5 kg/ml adducin or the NHZ-terminal domains to carbon
coated grids (Ted Pella Inc., Irvine, CA), which were washed with 10 mM
sodium phosphate, 1 mM Na EDTA, 0.5 mM DTT, pH 7.5, and coated with
1% uranyl formate.
ComputerAnalysis ofSequence Data
The nucleotide and amino acid sequences of adducin subunits were ana-
lyzedusing the MacVector Program (InternationalBiotechnology Inc., New
Haven, CT). Comparison of sequences of adducin subunits was performed
withthe BESTFIT Program ofUniversity ofWisconsin Genetics Computer
Group (UWGCG, Madison, WI). Database searches were performed using
the WORDSEARCH program and sequence alignments were made using
LINEUP and PROFILE programs of UWGCG. Potential phosphorylation
sites were identified by the PC Gene program, Prosite (Intelligenetics,
Mountain View, CA) .
Results
Isolation and Characterization ofHuman
Adducin cDNAs
A human reticulocyte lambda gtll library (7) was initially
screened with an antibody that recognized both subunits of
adducin with equal affinity. Two clones were isolated which
hybridized with one another. The deduced amino acid se-
quence from cloneR8 revealed an open reading frame which
contained an identical match with the sequences of four pep-
tides isolated from a tryptic digest of adducin (corresponding
to 62 residues), confirming that clone R8 encoded a portion
of one ofthe adducin subunits. The presence ofa stop codon
in clone R8 (followed by several other stops in all reading
frames) indicated that the sequence represented the 000H-
terminal coding and 3' untranslated region of one adducin
subunit. Several overlapping clones encoding the complete
subunit were isolated by subsequent screening of the reticu-
locyte and K562 libraries (Fig. 1 a).
Antibodies raised against the individual subunits of addu-
cin were not completely specific to one subunit and could
therefore not be used to determine the subunit encoded by
clone R8. Therefore, clone R8 was expressed in bacteria, and
the expressed fusion protein was used to isolate antibodies
specific forthis polypeptide. Antibody isolated from antisera
raised against intact adducin reacted selectively with the al-
pha subunit, indicating that clone R8 encoded the alpha
subunit of adducin (data not shown).
Clones for beta adducin could not be isolated from the
reticulocyte library despite repeated antibody screens, but
were obtained from a K562 human erythroleukemia cell li-
brary using the following approach. Four peptides (corre-
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sponding to 79 residues) matched identically with portions
of amino acid sequence derived from a 540-bp partial mouse
spleen adducin cDNA sequence (35) . These peptides also
matched the deduced amino acid sequence from alphaaddu-
cin clone R8 in small segments, suggesting that the peptides
were related but not identical to alpha adducin and repre-
sented beta adducin. Oligonucleotide primers were synthe-
sized based on mouse adducin cDNA sequence in the por-
tions that matched with peptide sequence. These primers
were used to synthesize a 300-bp cDNA fragment from
K562 mRNA reacted with reverse transcriptase to synthe-
size cDNA followed by amplification of cDNA with the poly-
merase chain reaction (Gilligan, D. M ., R. Joshi, E . Otto,
T. McLaughlin, and V. Bennett. 1990. J. CellBiol. 111:46a.)
The 300-bp cDNA was subcloned and sequenced and
showed 87 % nucleotide identity with the mouse spleen addu-
cin sequence. Two clones (Kl l and K3), obtained by screen-
ing the K562 library with the 300-bp probe, overlapped by
60 by and together encoded a protein with an open reading
frame of 726 residues (Fig. 1 b) . The predicted amino acid
sequence obtained from the composite cDNA sequence of
beta adducin clones was clearly distinct from that of alpha
adducin confirming that the clones indeed encoded the beta
subunit of adducin.
The nucleotide and predicted amino acid sequences for alpha
and beta adducin are shown in Fig. 2. It was not possible to
directly ascertain the NHZ-terminal sequence by protein se-
quence since the NHZ-terminus of both adducin subunits is
blocked (23) . However, the presence of stop codons in all
reading frames upstream of the proposed start site suggests
that translation starts at the methionine indicated in this
figure. The predicted initiation codon is followed by an open
reading frameof2211 nucleotides (737 residues) in alpha ad-
ducin and 2,178 nucleotides (726 residues) in beta adducin.
Alpha adducin has a long 3' untranslated region of 1,540 bp,
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Figure 1. Restriction maps and
alignment of cDNA clones for
alpha (a) and beta (b) addu-
cin. The composite cDNAs
were created fromoverlapping
clones. The prefix K or R des-
ignates the library (K562 or
reticulocyte) from which the
clone was isolated . The open
reading frame is indicated by
across-hatched box. AUG and
UGA represent the start and
stop codons. A polyadenylation
signal (AAUAAA) is present
13 by upstream of a poly A
tail on clone R301.
which contains a polyadenylation signal 13 nucleotides 5'to
a poly A tail .
The molecular weight of adducin calculated from the
amino acid sequence (alpha = 81 kD; beta = 80 kD) is
smaller than that predicted by SDS-PAGE (M alpha = 103
kD; beta = 97 kD). The discrepancy between predicted mo-
lecular weight and the relative molecular weight is due to
anomalous migration of adducin polypeptides on SDS elec-
trophoresis. Plots of migration as a function of polyacryla-
mide concentration provide a way of extrapolating migration
rates to zero polyacrylamide where proteins binding equiva-
lent amounts of SDS per gram of protein will have equal mi-
gration rates. Migration ofadducin polypeptides extrapolates
to a lower rate than standard proteins (data not shown) indi-
cating that these polypeptides either bind less SDS per gram
or that they have a net basic charge. Since the measured pl
ofadducin is less than seven(23), the most likely explanation
is reduced binding of SDS. The COOH-terminal domain of
adducin polypeptides is hydrophilic and is likely to be re-
sponsible for reduced electrophoretic migration. In support
of this interpretation, the expressed fusion protein compris-
ing the COOH-terminal domain of alpha adducin migrated
at 105 kD instead of the actual molecular weight of 85 kD
(not shown) . Finally, further evidence that the deduced se-
quence is complete is that the total number of nucleotides
sequenced for alpha adducin (3,936 bp) is very close to the
observed mRNA of 4 kb (Fig. 6) .
The deduced amino acid sequences for alpha and beta ad-
ducin are strikingly conserved, with an overall identity of
49% and a similarity of 66% (Fig. 3). The similarity is
greater towards the NHZ-terminal half of adducin (56%
identity, 76% similarity) consistent with conclusions from
peptide map analysis (23). However, stretches of closely
related sequences are distributed along the entire length of
these polypeptides. The COOH-terminal end of both
subunits contains an identical 22 amino acid highly basic do-
main (11 lysine residues) . This domain is similar to a domain1 GGGACCGGCGCTCAGCTGGCGGCGCGCTCGCCGGCCGAGGTGGGTCCCCAGGCCTCTCCAGTCCGCCGGGGCG
76 CACCACCGGCCCGTCTCGCCCGCCGCGCCGGGGAGCTGGAGCACGAGCGCACGTGTTAGGAACCTAGAAAGATTG
151 TACAATGAATCCI'GATTCTCGTGCTGCGGTGGTGACCTCACCACCCCCGACCACAGCCCCTCACAAGGAGAGGTA
I
￿
M N G D 5 R A A V V T 5 P P P T T A P R K E R Y
226 CTTCGACCGAGTAGATGAGAACAACCCAGAGTACTTGAGGGAGAGGAACATGGCACCAGACCTTCGCCAGGACTT
25 F D R V D E N N P E Y I . R E R N M A P D L A O D F
301 CAACATGATGOAGCAAAAGAAGAGGGTGTCCATGATTCTGCAAAGCCCTGCTTTCTGTGAAGAATTGGAATCAAT
50 N M M E 0 X X R V S M I L 0 S P A F C E E L E S M
376 GATACAGGAGCAATTTAAGAAGGGGAAGAACCCCACAGGCCTATTGGCATTACAGCAGATTGCAGATTTTATGAC
75 1 Q E 0 F K K G X N P T G L L A L 0 0 I A D F M T
451 CACGAATGTACCAAATCICIACCCAGCAGCTCCGCAAGGAGGGATGGCTGCCTTAAACATGAGTCTTGGTATGGT
100 T N V P N V Y P A A P Q G G M A A L N M S L G M V
526 GACTCCTGTGAACGTCTTAGAGGTCTGTTCTATTGCGTATGCAAAGGAGAGAAGTTATTACGGTGTAAATT
125 T P V N D L R G S D S I A Y D K G E K L L R C K L
601 GGCAGCGTTTTATAGACTAGCAGATCTCTTTGGGTGGTCTCAGCTTATCTACMTCATATCACAACGGGTGAA
150 A A F Y R L A D L F G X 5 Q L I R N H I T T R V N
676 CTCCGAGCAGGAACACTTCCTCATTGTCCCTTTTGGGCTTCTTTACACTGAAGTGACTOCATCCAGTTTGGTTAA
175 S E 0 E H F L I V P F G L L Y S E V T A S S L V K
751 GATCAATCTACAAGGAGTATACTAGATCGTGGAAGCACTAATCTGGCAGTGAATCAGGCCGGCTTCACCTTACA
200 I N L 0 G D I V D R G S T N L G V N Q A G F T L H
826 CTCTGCAATTTATGCTGCACGCCCGGACGTGAAGTGCGTCGTGCACATTCACACCCCAGCAGGGGCTGCGGTCTC
225 S A I Y A A R P D V K C V V R I R T P A G A A V 8
901 TGCAATGAMTGTGGCCTCTTGCCAATCTCCCCGGAGGCGCTTTCCCTTGGAGAAOTGCCTTATCATGACTA`.CA
250 A M K C G L L P 1 3 P E A L 5 L G E V A Y H D Y H
976 TGGCATTCTGGTTGTGAAGAGGAAAAAGTTTTGTTCAGAAAAATCTGGGGCCTAAAAGCAAGGTTCTTATTCT
215 G I L V D E E E X V L I 0 K N L G P X S K V L I L
1051 CCGGMCCATGGGCTCGTGTCAGTTGGGGAGCGTTGAGGAGGCCTTCTATTACATCCATAACCTTGTGGTTGC
300 R N H G L V 5 V G E S V E E A F Y Y I H N L V V A
1126 CTGTGAGATCCAGGTTCGAACTCTGGCCAGTOCAGGAGGCCAGACARCTTAGTCCTGCTGAATCCTGAGAAGTA
325 C E I Q V R T L A 5 A G G P 0 N L V L L N P E K Y
1201 CAAArCCAAGTCCCGTTCCCCAGGGTCTCCGCTAGGGGAAGGCACTGGATCGCCTCCCAAGTGGCAGTTGGTGA
350 R A K S R S P G S P V G E G T G 3 P P X N Q I G E
GCAGGAATTTGAAGCCCTCATGCGGATGCTCGATAATCTGGGCTACAGAACTGGCTACCCTTATCGATACCCTGC
375 Q E F E A L M R M L D N L G Y R T G Y P Y R Y P A
1276
1351 TCTGAGAGAGAAGTCTAAAAAATACAGCGTGTGCAGGTTCCTGCTAGTGTCACAGGTTACTCCTTTGCTAGTG
400 L R E K 9 X X Y S D V E V P A S V T G Y 3 F A 3 D
1
426 CGGTGATTCCGGCACTTGCTCCCCACTCAGACACAGTTTTCAGAAGCAGCAGCGGGAGAAGACAAGATGGCTGAA
425 G D 5 G T C 5 P L R H 3 F 0 K 0 0 R E K T R N L N
1501 CTCTGGCCGGGGCGCGAAGCTTCCGAGGAAGGGCAGAATGGAAGCAGTCCCAAGTCGAAGACTAAGTGGACTAA
450 S G R G D E A 5 E E G Q N G S 9 P X S K T K N T K
o
1516 AGAGGATGGACATAGAACTTCCACCTCTGCTGTCCCTAACCTGTTTGTTCCATTGAACACTAACCCAAAAGAGGT
475 E D G R R T S T S A V P N L F V P L N T N P K E V
1651 CCAGGAGATCAGGAACAAGATCCGGAGCAGAATTTACAGGACATTAAGCGGCTGGCCCTCAGTCCCAGGTTTT
500 OEM R N K I R E Q N L Q D I K T A G P O S O V L
1326 GTGTGGTGTAGTGATGGACAGCAGCCTCGTCCACGGAGAGCTGOTGACGGCCTCCAAGGCCATCATTGAAAAGGA
525
1801 GTACCAGCCCCACGTCATTGTGAGCACCACGGGCCCCAACCCCTTCMCACACTCACAGACCGTGAGCTGGAGGA
550 Y O P H V T V 3 T T G P N P F T T L T D R E L 8 E
1876 GTACCGCAGGGAGGTGGAGAGQAAGCAGMGGGCTGTGAAGAGMTCTGGACGAGGCTAGAGAACAGAMGAAM
575 Y R R E V E R K Q K G C E E N L D E A R E 0 K E X
1951 GAGTCCTCCAGACCAGCCTGCOGTCCCCGCCCGCCTCCCAGCACTCCGTCAAGCTGGAGGAGACCTTGTGCC
600 S P P D 0 P A V P H P P P S T P I K L E E D L V P
2026 GGAGCCGACTACTGGAGATGAGGTGATGCTGCCACCTTTAAGCCAACTCTCCCCGATCTGTCCCCTGATGAACC
625 E P T T G D D S D A A T F K P T L P D L S P D E P
2101 TTCAGAAGCACTCMCTTCCCAATGTTAGGAAGGAGGAOGAAGCCCATAGACCCCCAAGCCCCACTGAGGCCCC
650 S E A L G F P M L E X E E E A H R P P S P T E A P
2176 TACTGAGGCCAGCCCCGGCCAGCCCCAGACCCAGCCCCGGTGGCTGAAGAGGCTGCCCCCTCAGCTGTCGAGGA
675 T E A S P E P A P D P A P V A E E A A P S A V E E
2251 GGGGGCCGCCGCGGCCCTGGCAGCGATGGGTCTCCAGGCAAGTCCCCGTCCAAAAAGAAGAAGAAGTTCCGTAC
100 G A A A D P G S D G S P G K 5 P 9 K K K K K
2326 CCCGTCCTTTCTGAAGMGGCAAGAAGAAGAGTCACTCCTGAAAGCCCTGCGCTAACACTGTCCTGTCCGGGC
725 Y S F L K K S K K K 3 D S
2401 GACCCTGGCTCTGCCAGCGTCCCCGGCCACGTCTGTGCTCTGTCCTTGTGTAATGGAATGCAAAAAAGCCAAGCC
2476 CTCCGCCTAGAGGTCCCCTCACGTGACCAGCCCCGTGTAGCCCMGGCTGACCCAGTGTGTGCTCAGCAGCCCCA
2551 CCCCACCCTGCCCCTTGTCCTCTCAGAGCCTCAQCTTCTGGGGGAGACATGCTCTCCCGCAGGGGGGAGGGCT
2626 AAGTCATGGTCCTGGCTGGAAGGTACTGAACGCTTCTGCAGCTTTGCCTGCACGTCACCCTCCTGACCCTCACCT
2701 TTCCTGCCGTCCCTCCTGTTGTGAAATCACCACATTCTGTCTCTGCTTGGCTTCCCCTCCACCCTAAAGTCTCAG
2776 GTGACGGACTCAGACTCCTGGCTTCATGTGGCATTCTCTCTGCTCAGTGTCTCACTTAAATCTATATACAAAGC
2851 CTTGGTCCCGTGAAAACACTCCTGTGCCGCCAGCGGCCTTGAAGAGGCAGGTCTGGCCCAGTGCTGGGCAGG
2926 AACCCCAGCGGCAGTGGC.CCTGTGTGCACCCAACGTGATGCTATGGTGTCTGCCGACGATCCCTCGCCAG
3001 ATCAGATTCAGGGCTCAGTTTCTTTTTGCTTGGGTCTCTGGATTCCTGTCATAGGGAAGCTATATCAGGAGGG
3076 GAAGAGGCCTTTCTAGAATTTTCTTTGAGCAGGTTTACAATTTAGCTTACATTTTTCGACTGTGMCGTGMTAG
3151 CCTGCTTTTTGCTTTCTTCTTTCGGACCCCACAGTAGAGCACTrTTCACTTATTTGGOGGAGGCTTCAGGGGAC
3226 TGTTCTCACCTTAACTCAGCCAGAAAGATGCCCTAGTTGTGATCAAAGGTAACTCGAGGTGGGGGTAGCCCTGG
3301 GGCCCCTCGCATCACCGTCATTGTGGAGCCTGAACCGTGTGCTCCTCGGCAGTGCTGTTGTTGTTACTTCCC
3376 TCCAAGAGGCTGGAAAAGGGCTCAGAGCTGCTGAGCAGGAACCGGAGGGTCACCCATr?CAGGAGGTGCCGGTAC
3451 CAGCCTGACTAGGTACAGGCAAGCTTGTGTGGGCCCAAGGGCCCTTGGTAGGCTGGTGCCAGATGTGGGCTCA
3526 GATCCTGGGCATGATGGGCCGAGCCACCTCGGTCCCACTGATTGGCCAGCCGAGCGCAACCAGGCTOCTGCAT
3601 GGCACTGCCGCCGCTTCCAGCTTCCTCTGAGCCGCAGGGCCTGCTACGCGGGCAAGCOTGCTGCCTCTCTTCTG
3676 TGTCGTTTTGTTGCCAAGGCAGAATGAAAAGTCCTTAACCGTGGCTCTTCCTTTATCCCCTCCTTTACCCCAG
3751 TATGCAATGCTTTTAATTTTCACTTTTGTIIGTTTAATCCTTTGTATTACAACATGAAATATA~GTTO- CA TT 'ATATG
3826 GACACCGACTTGGGAGGGGGTCCTGAATGTCCTTTCTCCAGTGTMCATGTTTTACTCACgDpypp~nTTCTT
3901 TCACC
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1 CTTCAACTCCTACATACTTCCCCCTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGAATGTCTQCACAGCCGCT
76 TTCCACACAGACATCATAACAAAAAATTTCCACCAAACCCCCTCCCCCCGCTTCTGGCCACACCAMTAAACACA
151 TCTCTGCCAAACCCATAAAATAACAAAACCAACCCGCAGTGGCCGACCGGAGATAGCTAAGATGCCGCGCAGGAG
226 TTTCCACCTGGATGTTTGAGGTTGTGTAGATGTGGCCGGCMCCTTGAGAGTGGAGCTAGGGGGTGCAGACTGAG
301 CAGTGAACAGAAGGAGCCTTGGACAGGGCTGGGCCAGCCTCCCGAGTTCCAGGAGCGAATTGCAAACCCACCGGG
316 AAAATGAGCGAAGAGACGGTCCCCGAGGCTGCCICGCCGCCGCCCCCGCAGGGGCAGCCTTACTTTGNCCGCTTC
1
￿
M 3 E E T V P E A A S P P P P Q G Q P Y F D R F
451 TCAGAGGACGACCCCGAGTACATGCGCCTTCGCAACCGGGCGGCGGACCTGCGGCAGGACITCAACCTGATGGAG
25 S E D D P E Y M R L R N R A A D L R O D F N L M E
526 CAGAAGAAGCGCGTCACCATGATCCTGCAGAGTCCCTCfTTCAGGGAGGAGCTGGiU1GGCCTCATCCAGGAGCAG
50 -Q- IL K R V T M I L Q 3 P S F R E E L E G L I Q E 0
601 ATGAAGAAGGGGAACMCTCCTCCAACATCTGGGCCCTGCGACAGATCGCGGACTTCATGGCCAGCACCT000AC
75 M K K G N N S S N I N A L A 0 I A D F M A 8 T S H
676 GCAGTCTTCCCGACATCTTCCATGAATGTCTCCATGATGACGCCTATCAATGACCTCGCACAOCTGACTCCCTG
100 A V F P T 3 S M N V S M M T P I N D L H T A D S L
751 AACCTGGCCMAGGGGAGCGGCTCATGCGGTGCAAGATCAGCAGTGTCTACCGCTCCTGGACCTCTATGGCTGG
125 N L A K G E R L M R C X I S S V Y R L L D L Y G N
826 GCCCAGCTGAGTGGCCTATGTCACGTTGGAGTCAGCAAGGGCAGGACCACTTCCTGTCAGCCCTAAGGGA
150 A Q L S D T Y V T L R V S K E Q D H F L I 9 P X G
901 GTTTCTTGCAGTGAAGTCACAGCGTCCAGCCTGATCAAGGTGMCATTCTGGGAGAGGTGGTGGAGAAGGGCKC
175 V 5 C 5 E V T A S 5 L I X V N I L G E V V E K G S
976 AGCTGCTTCCCAGTGGACACCACAGGCTTCTGTCTGCACTCGGCCATCTATGCAGCGAGGCCCGACGTGMCTGC
200 S C F P V D T T C F C L H S A I Y A A R P D V R C
1051 ATCATCCACCTGCACACACCGGCCACAGCAGCGGTGTCGGCCATGAAGTGGGG:CTCCT000TGTCTCCCACAAT
225 I 1 H L H T P A T A A V S A M K N G L L P V S H N
1126 GCCCTGCTGGTGGGGGACATGGCCTATTATGACTTCAATGGGGAAATGGAGCACGAAGCCGATCGGIITCAACGTG
250 A L L V G D M A Y Y D F N G E M E Q E A D R I N L
1201 CAGAAGTGCCTTGGACCCACCTGCAAGATCCTGGTGCTAAGAAACCATGGAGTGGTTGCTCTGGGTGACACGGTA
275 Q K C L G P T C K I L V L R N H G V V A L G D T V
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1801 ATGCCGATTCGCATCGAAAACCCAAACCAATTTGTGCCTCTCTATACTGACCCCCAGGAAGTACTGGAGATGAGG
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Figure 3. Bestfit analysis of amino acid sequences for alpha and beta adducin. Sequences were aligned using the Wisconsin Genetics Com-
puter Group program. Lines indicate identical residues, two dots indicate conservative substitutions. Sequences have 49% identity and
66% similarity. Asterisks indicate potential phosphorylation sites.
in the MARCKS protein which contains protein kinase C
phosphorylation sites and exhibits calmodulin binding (19).
Adducin is a major substrate for protein kinase C and con-
tains multiple potential protein kinase C phosphorylation
sites (Fig. 2) . Several of these predicted protein kinase C
sites are in a strategic location at the junction between head
and tail domains (see below) . Additional potential sites are
in the COOH-terminal basic stretch noted above. The
predicted sites are most likely not all utilized by protein ki-
nase C since adducin incorporates only 2-3 mols of phos-
phate per mol (3, 27, 39). At leastone ofthe sitesat thejunc-
tion between head and tail domains is phosphorylated under
in vitro conditions, since progressive proteolysis of adducin
phosphorylated by protein kinase C yields a labeled polypep-
tide of M, = 48,000, while polypeptides of lower relative
molecular weight are not labeled (Joshi, R., and V. Bennett,
unpublished data) . Two potential protein kinase A siteswere
detected in alpha adducin at residues 407 and 734 . Addi-
tional predicted sitesare presentin the head domains, but are
not phosphorylated in vitro (23) and therefore not included
inthis analysis. Consensus sequences for phosphorylation by
cdc2 kinase and cGMP-dependent protein kinase also are
present, although it is not known whether adducin is a sub-
strate for these kinases.
Potential calmodulin binding sites are residues 425-444
and 705-721 in beta adducin, based upon an aromatic resi-
due in a region exhibiting some segregation of polar and hy-
drophobic residues in a helical wheel diagram (32). Residues
705721 of beta adducin are identical to residues 718734 in
alpha adducin and may be a calmodulin binding site in both
subunits. Calmodulin binds preferentially to the beta subunit
of erythrocyte adducin (13), although a loweraffinity interac-
tion with the alpha subunit could also occur.
Domain Structure ofAdducin
Previous mapping of domain structure of adducin by con-
trolled proteolysis has revealed two major subdivisions
Figure 2. Nucleotide and deduced amino acid sequences for human erythrocyte alpha (a) and beta (b) adducin. Underlined amino acids
were identical to sequences of peptides isolated from proteolytic digestion of adducin. Potential protein kinase C phosphorylation sites
in the COOH-terminal domains of adducin are indicated by asterisks (PC Gene Prosite Program, Intelligenetics). The polyadenylation
signal for alpha adducin is boxed. These sequence data are available from EMBL/GenBank/DDBJ under accession numbers X 58141 for
alpha and X 58199 for beta adducin.
Joshi et at. Primary Structure of Human Adducin
￿
669B
m
C
2
CU
c
0 d
0
á
Û
L
0-
2
û
2
2
-2 ~
helix
sheet
turn
helix
sheet
turn
I
￿
.
100 200 300 400
within each polypeptide: a protease-resistant NH2 terminal
domain of M = 39,000 and a protease-sensitive 000H-
terminal region (23) . A stable chymotryptic fragment ofM
= 48,000 also has been noted (3, 23), suggesting a subdo-
main of M = 9,000 between the protease-sensitive and
protease-resistant domains. The hydrophilicity profile ofad-
ducin subunits is consistent with results from protease diges-
tion, and resolves distinct regions within the primary se-
quence. The COOH-terminal regions from residues 350-737
(alpha) and 338726 (beta) are highly enriched in hydro-
philic residues, while the NH2-terminal segments contain a
mixture of hydrophobic and hydrophilic residues (Fig. 4) .
The hydrophilic domain does contain a few regions with less
polar residues, and one of these occurs between residues
410-430 (alpha) and 398-420 (beta) . The residues from 350
to 430 (alpha) and 338-418 (beta) would correspond to the
M = 9,000 subdomain noted above. This profile is consis-
tent with three distinct domains in adducin: a N112-terminal
protease-resistant domain of 350 residues followed by a 80
residue subdomain and ending in a protease-sensitive 300
residue COOH-terminal domain. Secondary structure pre-
dictions shown in Fig. 4 suggest that the COOH-terminal do-
mains have multiple stretches of predicted alpha helices in-
terrupted by regions rich in proline residues.
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Figure 4. Analysis of alpha
and beta adducin amino acid
sequences. (A) Hydrophilicity
profiles of alpha and beta ad-
ducins. Plotswere determined
using the MacVector program
(International Biotechnologies
Inc.) and a window length
of 7 residues. (B) Secondary
structure analysis ofalpha and
beta adducin according to the
method of Chou and Fasman
showing predicted regions of
alpha helix, beta sheet, and
turns. (C) Schematic model
of folding of an adducin sub-
unit (equivalent for alpha and
beta subunits).
Physical properties ofadducin as compared to those ofthe
NH2-terminal domains suggested that while adducin is rela-
tively asymmetric with a frictional ratioof 1.5-1.8 (3, 13, 39),
the N112-terminal domains are approximately spherical in
shape (23) . One interpretation based on this information is
that the COOH-terminal domain forms a tail which is the
primary contributor to the asymmetry observed in intact ad-
ducin. The maximum length of the tail would be 45 nm if
it is organized as an extended alpha helix (0.15 nn/residue),
although the presence of multiple proline-rich turns suggests
a more contorted folding. Two predictions that could be
tested by EM are that a tail should be observed and that the
isolated NH2-terminal domain would have the same dimen-
sions as the globular portion of intact adducin. Extended
tails have not been noticed previously in adducin by rotary
shadowing and the molecule was predicted to be an oblate
ellipse (13) . However, a negative result is difficult to inter-
pret since tails have been difficult to visualize in other pro-
teins such as synapsin (21, 37).
A careful reexamination of rotary shadowed images of ad-
ducin (Fig. 5) demonstrates the presence of tails on some
molecules (ti10 per cent in this experiment). In some exam-
ples, the tails appear folded into globular structures at their
ends. The maximum lengths of these folded tailswere ti5-6F
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.nm . The diameters of tails are difficult to estimate since
these values are close to the size ofthe platinum grains . Sizes
of the globular structures observed in adducin and the NH2-
terminal domains were very similar in rotary shadowed im-
ages (Fig . 5) . The major structure visualized in these elec-
tron micrographs therefore is comprised of the NH 2 -
terminal domain . These results support the prediction from
analysis ofamino acid sequence that adducin contains a head
domain and a flexible tail .
The diameter of the most prevalent structure in intact
adducin and NH2-terminal domains is 20 nm in shadowed
images, although smaller structures of 12 and 8 rim also are
evident (Fig. 5) . The 20-nm forms comprised -70% of in-
tact adducin structures (157 out of 218) and 50% of NH 2 -
terminal domains (130 out of 267) .
The heterogeneity in size of adducin could result from a
mixture ofmonomers and dimers or of dimers and tetramers
(see Discussion) . Some insight into whether the large images
represent dimers or tetramers can be gained by comparison
of the actual size with values predicted from calculations
based upon the approximately spherical shape indicated by
physical properties of the NH2-terminal domain (23) . The
size of the 20-nm structure visualized by platinum shadow-
ing includes the contribution ofmetal in addition to protein .
A more accurate estimate ofthe size of the protein is 10-
12-nn based on negative staining of adducin (13) . Minimum
sizes of dimers and tetramers of the NH2-terminal domain
are 5.6 and 7.1 nm, respectively, if these are folded into a
smooth sphere (from the relationships V = mol wt (partial
specific volume)/Avogadros number) and V = 4/3 R 3 ) .
More realistic values taking into account hydration would be
7.1 nm, and 8.9 run for dimers and tetramers, respectively
(calculated assuming only 50 per cent of the volume is pro-
tein and the rest is water) . These calculations indicate that
the 10-12-tun structures are probably tetramers of NH2-
terminal domains and that smaller structures are dimers .
Expression ofAlphaandBeta AdducinmRNA
Alpha adducin clone R107 hybridized to a single band of 4.0
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kb in a Northern blot ofRNA from various rat tissues (liver,
brain, kidney, and spleen), human reticulocytes, and K562
cells (Fig. 6, left panel) . The amount of alpha adducin
mRNA in liver (laneA) ismuch less than in kidney (lane B),
brain (lane C), or spleen (lane D) . The level ofalpha adducin
mRNA in 10 hg of poly A RNA from kidney, brain, or
spleen is similar to the amount of alpha adducin mRNA de-
tected in 10 hg of total RNA from K562 cells (lane E) or
reticulocytes (lane F), suggesting greater expression inK562
cells and reticulocytes .
On a duplicate blot, beta adducin clone Kl l hybridized to
mRNAs of several different sizes . Liver and kidney (lanes A
and B) have no detectable beta adducin mRNA, in contrast
to alpha adducin (lanesA andBin the leftpanel) . Beta addu-
cin clone Kll hybridized to an 8.1-kb mRNA in brain (lane
C) and, on longer exposure, to 4.0- and 3.8-kb mRNAs (data
not shown) . In spleen (lane D), threemRNAs are evident of
3.7, 3.3, and 3.0 kb . In total RNA from K562 cells (lane E),
two major transcripts were detected of4.0 and 3.8 kb . In con-
trast to alpha adducin (lane F in the left panel), much less
beta adducin mRNA was present in reticulocytes (lane F)
and required poly A selection and longer exposure for detec-
tion (lane F) .
The major differences in levels of alpha and beta adducin
mRNAs in kidney, liver, and reticulocytes indicate unequal
stability of alpha and beta adducin mRNÁs and/or distinct
transcriptional regulation . Another striking contrast be-
tween the Northern blots for alpha and beta adducin is
provided by the observation that a single-sized mRNA from
spleen, K562 cells, and brain hybridizes to the alpha adducin
probe while mRNAs of several different sizes hybridize to
the beta adducin probe .
Sequence Similarity ofAdducin Subunits with the
Actin-bindingDomainsoftheSpectrin/Actin-binding
Protein SuperFamily
Database searches with alpha and beta adducin amino acid
sequences did not show any extended homology with known
proteins . However, an interesting similarity was noted be-
672
Figure 6. Detection of alpha
and beta adducin mRNAs in
various tissues by Northern
blot analysis . Duplicate blots
were hybridized to 32P-labeled
probes prepared by random
priming from alpha (8107) or
beta (K11)cDNAs . Lanes con-
tained 10 1Ag of either poly
A+ RNA from adult rat liver
(A), kidney (B), brain (C),
spleen(D), ortotalRNA from
human K562 (E) or reticulo-
cytes (F) . LaneF contained 5
wg of poly A+ RNA from hu-
man reticulocytes and was hy-
bridized to the PCR-derived
beta probe shown in Fig . 1 b .
Sizes from an RNA ladder
(obtained from Bethesda Re-
search Laboratories, Gaithers-
burg, MD) are indicated in kb
on the left .Figure 7. Comparison of alpha and beta adducin sequence with human alpha-actinin (42), human erythrocyte beta spectrin (41), human
dystrophin (25), Diciyostelium (Rd. ) ABP-120 (4), human endothelial ABP280 (18), and the first NH2-terminal repeat of chick fimbrin
(10). Amino acid positions are shown on either side of the aligned sequences. Shaded areas include identical residues and conservative
substitutions in comparison to the alpha-actinin sequence. Alignments between alpha-actinin and beta adducin (first two domains) and
between alpha-actinin and alpha adducin (third domain) were determined using the Bestfit program from the Wisconsin Genetics Computer
Group. The 27 amino acid domain essential for actin binding in Diciyostelium ABP-120 is indicated.
tween adducin and the highly conserved NH2-terminal F-ac-
tin binding domains of the spectrin superfamily (spectrin,
alpha-actinin, dystrophin) and certain actin gelation proteins
(ABP120, ABP-280, and fimbrin). A 27 amino acid segment
is 60-80 % conserved among these proteins and has recently
been shown to be essential for actin binding by ABP-120 (4) .
A computer assisted search ofadducin sequence with this 27
amino acid domain revealed a related sequence in the NH2
terminal globular domains of both subunits (Fig. 7). Alpha
adducin has nine identical residues and six conservative sub-
stitutions out of the 27 amino acid domain while beta ad-
ducin has four identical residues and 10 conservative sub-
stitutions. Two additional segments of similarity between
adducin and other actin-binding domains are revealed by in-
sertion of two gaps of 23 and 8 residues (Fig. 7). Interest-
ingly, human alpha-actinin is more closely related to beta
adducin than to other members of the family in this region.
No apparent similarities were found between adducin and
members of the actin capping/severing/depolymerization
family of proteins such as gelsolin, villin, etc.
Chromosomal Localization ofAlpha and Beta
Adducin Genes
Southern blots of genomic DNA from a panel of hybrid cell
lines with deletions of various human chromosomes suggests
that the alpha subunit is encoded by a gene located on chro-
mosome 4. Clone R107 (representing 2-kb-coding sequence
from alpha adducin) hybridized to cell lines containing chro-
mosome 4 in a panel of DNA from several human/hamster
hybrid cell lines (data not shown). Unfortunately, clone KlI
(representing beta adducin) did not hybridize to any cell line
suggesting that the chromosome carrying beta adducin was
absent in this panel . A careful analysis of the chromosomal
representation in these hybrid lines showed that chromo-
some 2 was present only in a single cell line. Controls rerun
by Bios Corp. suggested that chromosome 2 in the panel cell
line did indeed have a deletion. It is possible that beta addu-
cin is present on chromosome 2 although further experi-
ments are required to verify this localization .
Discussion
This report describes the complete primary sequence for al-
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27 amino acid domain
pha and beta subunits of human adducin, presents evidence
that the genes encoding these subunits are expressed in mul-
tiple tissues, and implicates the beta subunit as the most vari-
able and potentially limiting subunit in assembly of intact
adducin. The primary sequences of the subunits provide sev-
eral interesting insights into the structure and evolution of
adducin. Alpha and beta adducin are closely related with an
overall identity in amino acid sequence of 49 %, suggesting
evolution through gene duplication. The sequence data com-
bined with earlier analysis of domain structure (23) support
folding of adducin subunits into a globular N112-terminal
head domain linked by a connecting domain to an extended
tail. The tail of adducin would contribute to the high fric-
tional ratio noted previously (3, 13, 39), and has been visual-
ized in this report by EM (Fig. 5).
Separation of adducin into distinct domains or modules
suggests how this protein could associate selectively with
spectrin-actin complexes in preference to actin or spectrin
alone in in vitro assays (3, 14). Separate binding sites of low
affinity for spectrin and F-actin, one in the head and the other
in the tail, would result in weak association with individual
spectrin or F-actin molecules. However, providing adducin
and actin associate closely on spectrin, a spectrin-actin com-
plex would allow adducin to bind simultaneously with both
spectrin and actin. Participation of adducin in a ternary com-
plex as opposed to binary interactions with spectrin or actin
alone would be greatly favored due to the increase in the
effectiveconcentration ofinteracting sites. In thermodynamic
terms, ternary complexes are favored because of a reduction
in entropy related to rotation and diffusion ofthe interacting
proteins (for a discussion of quantitative aspects of multiva-
lent protein-protein associations see Jencks [22] and Erick-
son [ll]) . A flexible tail would be ideally suited for a role
requiring simultaneous association with two large molecules
such as spectrin and actin filaments. The head domain exhib-
ited no detectable binding to F-actin in co-sedimentation as-
says (23) . However, direct evaluation of activity of isolated
tails in binding to actin was not feasible since the tail was
destroyed by even mild proteolysis. It will be important in
future experiments to evaluate the roles of heads and tails of
adducin using recombinant polypeptides.
Physical properties and cross-linking experiments with ad-
ducin indicate that adducin subunits are assembled into sta-
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equilibrium (3, 13, 23) (see Results). Consideration of avail-
able information suggests a model where the first level of or-
ganization involves association of subunits into stable paral-
lel dimers involving tail-tail and head-head contacts. The
observation that removal of the tail by proteolysis results in
a major reduction in efficiency ofcross-linking ofadducin to
dimers and tetramers (23) may be interpreted as evidence for
extensive tail-tail contacts. An anti-parallel arrangement of
subunits is unlikely based on the size of the heads, which are
10-12run based on EM ofintact adducin (13) . A single head
of 39 kD folded into a sphere would have an expected di-
ameter of 6 nm (see Results). Evidence for head-head con-
tacts within dimers is based on cross-linking of isolated
heads to dimers, although this occurred with reduced yield
compared to intact adducin.
Several observations suggest that adducin dimers partici-
pate in a dimer-tetramer equilibrium that involves head-
head contacts. As discussed in Results, the 10-12-run struc-
tures visualized by negative staining (13) are approximately
the expected size for a tetramer comprised of 39-kD heads.
Isolated heads have a predicted molecular weight of 120 kD,
and are either trimers or a mixture of dimers and tetramers
(23). In support of a tetramer is the observation that the
heads can be cross-linked as tetramers (23) . A possible
model incorporating these observations would predict addu-
cin dimers associated by head-head contacts to form tetra-
mers. Tetramers with actin-binding domains located in their
tails would explain ability of adducin to bundle actin fila-
ments (31). Such a configuration also suggests how adducin
can recruit additional spectrin molecules to adducin-spec-
trin-actin ternary complexes (14).
Adducin sequence, while unique in the data bases exam-
ined, exhibits localized similarities to the MARCKS protein
at the COOH-terminus and to the actin-binding domains of
members of the spectrin/alpha actinin/dystrophin super fam-
ily in the NHz terminal head domain. The relationship of
adducin to MARCKS could result from the large number of
basic residues in both sequences and may not represent an
evolutionary relationship between these proteins. However,
the sharedbasic sequence could be offunctional significance.
For example, MARCKS has recently been reported to asso-
ciate with F-actin, and the basic sequence which also con-
tains sites of phosphorylation by protein kinase C was impli-
cated in this interaction (Hartwig, J. H., P A. Jammey, A.
Rosen, M. Thelem, A. C. Nairn, and A. Aderem. 1990. J.
Cell Biol. 111:8a). The similarity between adducin and
members of the spectrin superfamily is more extensive and
may reflect a distant relationship between adducin and other
members of the superfamily. The functional significance of
the sequence similarities between adducin and actin-binding
proteins is not clear, since the related sequence is located in
the head domain of adducin which does not associate with
F-actin (23). Theactin-binding domains ofspectrin and other
proteins have additional functions such as binding to acces-
sory proteins or to an adjacent subunit. The sequence shared
with adducin thus may be involved in an activity unrelated
to actin-binding. In any event, the regions of sequence simi-
larity to MARCKS and actin-binding proteins are candidates
for site-directed mutagenesis and deletions in future explora-
tion of active sites of adducin.
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An unanticipated implication of data presented in this
study is that the same genesencoding alpha and beta adducin
are expressed in other tissues. Alpha adducin probes hybrid-
ize under conditions of high stringency with a mRNA of
identical size in multiple tissues. While alpha adducin has
not been characterized by sequencing of cDNA, it is likely
that the mRNAs are very similar or identical. A portion of
the beta adducin gene is expressed in brain based upon the
sequence of a partial cDNA clone isolated from a human
brain cDNA library which is identical to erythrocyte beta
adducin (Gilligan, D. M., T. McLaughlin, and V. Bennett,
unpublished observations) . Other erythrocyte membrane-
skeletal proteins encoded by identical genes expressed in
other tissues include ankyrin (referred to as ankyrinR to
distinguish this isoform from other members of the family)
(26, 34), and the beta subunit of spectrin (41). These consid-
erations indicate that detailed analysis of proteins such as
erythrocyte adducin will be relevant in the context of other
tissues.
Expression of mRNAs encoding alpha and beta adducin
are subject to distinct regulation. A striking divergence be-
tween message levels occurs in reticulocytes which have at
least 20-fold higher levels of alpha adducin mRNA relative
to beta adducin mRNA (Fig. 6) even though the polypeptide
subunit stoichiometry of alpha and beta adducin is 1:1 in ma-
ture erythrocytes. Further studies will be required to resolve
whether alpha and beta adducin mRNAs have differences in
stability or translation efficiency. One possibility is that rapid
turnover of beta adducin mRNA may limit the synthesis of
beta adducin subunits and thereby regulate the assembly of
adducin heterodimers. Analysis of adducin mRNA in other
tissues reveals different levels ofexpression ofalphaand beta
subunits as well as several size mRNAs related to beta addu-
cin. Alpha adducin mRNA is detected in liver and kidney
while beta adducin mRNA is not, suggesting that alpha ad-
ducin may be expressed without beta adducin. However, it
is also possible that in liverand kidney beta adducin mRNA
is degraded rapidly whilealphaadducin mRNA is relatively
stable.
Alpha adducin expression has been noted in the absence
of beta adducin inhuman fibroblasts and keratinocytes based
ondetection ofimmunoreactive polypeptides (24, 40). These
observations suggest either that beta adducin variants are
present that do not react with antibodies or that homodimers
of alpha adducin are functional. Evidence for selfassociation
between alpha subunits is provided by cross-linking with
O-phenanthroline/copper which forms disulfide bonds be-
tween adjacent cysteine residues. Alpha adducin was com-
pletely cross-linked to higher forms by this reagent leaving
a portion of the beta subunit in an uncomplexed form (13) .
It will be ofinterest to evaluate properties ofrecombinant al-
pha and beta adducin to determine if these polypeptides can
assemble into homo-dimers and tetramers and to evaluate
functional activities.
The observation of several size mRNAs hybridizing to the
beta adducin probe suggests possibilities of splicing or other
posttranscriptional modifications of pre-mRNA. A partial
cDNA sequence for mouse spleen beta adducin (35) exhibits
98% identity with humanbeta adducin for 149 amino acids,
followed by 31 residues that abruptly diverge and may repre-
sent a splice site. The 8.1-kb beta adducin mRNA may also
674result from alternative splicing of pre-RNA, although the
possibility that this mRNA is encoded by a closely related
gene has not been excluded.
Mechanisms of site directed as opposed to random assem-
bly of structural proteins are crucial to understanding forma-
tion of a cell. Adducin has features that suggest such a role
as an assembly factor that has the potential to promote local-
ized organization of spectrin into a spectrin-actin lattice.
Adducin interacts with spectrin and actin according to an or-
dered pathway beginning with association ofspectrin and ac-
tin to form a spectrin-actin complex followed by association
of adducin, and finally by recruitment of a second spectrin
to the adducin-spectrin-actin ternary complex (3, 14) . One
consequence of such an ordered reaction is that assembly of
a spectrin-actin network could be directed to particular
regions of cell membranes where either spectrin or adducin
are concentrated. Sites of cell-cell contact in epithelial tis-
sues contain a stable complex of spectrin and adducin (24)
and are an example of a domain that may result by such a
directed assembly reaction. The structure of adducin sug-
gests a testable hypothesis for how this protein could partici-
pate in assembly of a spectrin-actin network. The availabil-
ity of adducin cDNAs will allow evaluation of these ideas in
in vitro assays and in the context of cells.
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